Background and aims: Few data are available regarding the dynamic changes in the
| INTRODUCTION
Chloride, despite flanking sodium as its anionic counterpart in salt, has remained largely ignored in heart failure (HF) pathophysiology. 1 Recent studies have demonstrated that changes in vascular [2] [3] [4] [5] and red blood cell volumes 5, 6 are independently associated with serum chloride concentration. Few studies, however, have evaluated the dynamic changes in serum chloride concentrations under HF pathophysiology. Therefore, the aim of this study was to investigate changes in the serum chloride concentration, including its relation to the serum sodium concentration, under worsening HF and its recovery following conventional diuretic therapy.
| METHODS

| Study population
The present study was a retrospective, single-center, observational study derived from a recent study 7 
| Data collection
The event of worsening HF was determined by the appearance of at least two of the following HF-related signs, whether or not changes in symptoms occurred: HF-related physical signs (the third heart sound, pulmonary crackles, and leg edema), fluid weight gain (≥1.5 kg), 8 and ultrasound pleural effusion. 9 If multiple episodes of worsening HF existed in a single patient, the first episode was selected for the present investigation. Worsening HF was treated by conventional therapy with a combination of loop diuretics, aldosterone blockade, thiazide diuretics, and/or inotropic drugs by oral and/or intravenous routes in the hospital or outpatient clinic. HF patients with severe renal failure (serum creatinine concentration > 3.5 mg/ dL at stable HF status) were excluded from the present analysis.
Peripheral hematologic and biochemical tests, except b-type natriuretic peptide measurement, were not routinely obtained for all patients of the original study because that study did not focus on the correlation between HF status and blood chemistry. Thus, the patients and blood data of the present study were not selected consecutively but were included based on the availability of complete blood data as well as simultaneous HF-related clinical data during clinically stable HF, worsening HF, and resolution of worsening HF after therapy. Findings from the follow-up examination were used to determine the optimal response (ie, resolution of at least two or more HF-related signs) to treatment for worsening HF and the clinical presentation of a return to stable HF status after therapy.
Blood tests included measurements of hemoglobin, hematocrit, total protein, albumin, electrolytes, blood urea nitrogen, creatinine, and serum b-type natriuretic peptide levels. In the present study, hyponatremia and hypochloremia were defined as a serum sodium con- Abbreviations: ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; EF, ejection fraction; NYHA-FC, New York Heart Failure functional class; HF, heart failure. Data are presented as number of patients (%), unless otherwise specified.
Bonferroni's correction was used for multiple comparisons. Correlations between two parameters were analyzed using Pearson's correlation and were demonstrated using scatter plots. All tests were two-tailed, and P value < 0.05 was considered statistically significant.
| RESULTS
Ambulatory patients with HF (n = 83) were enrolled and followed up at the outpatient clinic of Nishida Hospital between June 2003 and March 2009; of these, 47 had available data for analysis of the serum sodium and chloride concentrations at worsening of HF and its recovery. The remaining 36 patients were similarly followed up during the study period, but they did not experience an event of worsening HF, so they were not included in the present analysis. The characteristics of the 47 patients with clinical stability at study entry are summarized in Table 2 , and changes in serum sodium and chloride concentration are shown in Figure 1A The distribution of the serum sodium and chloride concentrations at worsening of HF and its recovery by conventional diuretic therapy in the 47 study patients is shown in Figure 3 . Among a total of 47 worsening HF events, serum sodium concentrations were positively correlated with serum chloride concentrations at worsening of HF (r = 0.822, P < 0.0001, Pearson's correlation; Figure 3A ) and its recovery following conventional diuretic therapy (r = 0.840, P < 0.0001; Figure 3B ). The incidence of hyponatremia was 11% (five patients),
and that of hypochloremia was 9% (four patients) ( Figure 3A) . After decongestive therapy, the incidence of hyponatremia increased to 23% (11 patients) and that of hypochloremia increased to 26% (12 patients) (Figure 3b ). Coexistence of hyponatremia and hypochloremia was observed in three patients (6%) at worsening of HF and in 10 (21%) following conventional diuretic therapy. The P value indicates the difference across all three groups. Differences between three groups were tested by two-way analysis of variance, followed by a multiple comparison post hoc test.
| DISCUSSION
In the last several years, the important role of chloride in the field of HF pathophysiology has been recognized. Some studies have strongly and independently noted the prognostic importance of hypochloremia in patients with chronic HF. 11, 12 Recent studies have revealed that chloride is a key electrolyte that regulates plasma volume during worsening HF 2,3 and its recovery following treatment with conventional diuretics, 4 leading to propose a unifying hypothesis, the "chloride theory" for HF pathophysiology, 3, 13 which states that changes in serum chloride concentration are primarily associated with changes in plasma volume and renin-angiotensin-aldosterone system activity in HF pathophysiology.
To date, most studies have investigated the body fluid dynamics in HF through the control of sodium, potassium, and water balance in the body. [14] [15] [16] Few data are available, however, regarding the dynamic changes in serum chloride concentrations under HF pathophysiology. Sodium and chloride concentrations are highly correlated at both worsening of HF and its recovery (Figure 3 ). Important differences, however, exist among individuals. Namely, under worsening of HF, discordant movement of chloride and sodium appeared in as many as nine of 47 patients (19% of study patients); increased sodium and Differences between three groups were tested by two-way analysis of variance, followed by Bonferroni multiple comparison post hoc test (Table 2 ). All data points are shown in the range plotted FIGURE 2 Relationships of absolute changes in the A, serum sodium and B, chloride concentrations from clinically stable to worsening heart failure and its recovery following conventional diuretic therapy. Changes in the serum sodium (r = −0.612, P < 0.0001, Pearson's correlation) or chloride (r = −0.55, P < 0.0001) concentrations from stable HF to worsening HF and its recovery after therapy are negatively correlated decreased chloride were observed in two patients, and decreased sodium and increased chloride were observed in seven patients.
Therefore, it is optimal to evaluate the changes in serum sodium and chloride concentrations under transition of HF status separately first and in combination after considering the possible role of each electrolyte in different HF states. 3 In the present study, absolute changes in serum chloride concentration from clinically stable to worsening HF and its resolution after conventional diuretic treatment were greater than those of the sodium concentration, indicating that chloride has greater effects on the serum osmolality or tonicity. 17 Mechanisms for this differential movement between serum sodium and chloride are unclear, but the handling of Na + /K + /2Cl through cotransporters in the nephrons may contribute to the greater changes observed in serum chloride concentration than in sodium concentration in HF pathophysiology. 18 Alternatively, recent insights suggest that sodium is not distributed in the body solely as a free cation but that it is also bound to large interstitial glycosaminoglycan networks in different tissues, which may have an important regulatory function for maintaining the serum sodium concentration by refilling sodium from the interstitial network into the blood. 19 Also, it should be kept in mind that changes in serum electrolytes may be multifactorial and interrelated, resulting from neurohormonal activation, renal dysfunction, medications, and dietary intake. chloride by lysine chloride administration 12 or hyperosmotic saline infusion, 23 or usage of acetazolamide. 24, 25 Additional studies are required to clarify the consequence of serum chloride modulation treatments in HF pathophysiology.
| LIMITATIONS
First, this study was performed with the use of a relatively small number of patients and was a single-center observational study and should thus be considered to be hypothesis generating. Second, the present results were derived from a population of mild-to-moderate HF patients. Therefore, the results of this study cannot be generalized to more advanced HF patients. Thus, a study including a larger number of HF patients is needed to better assess the dynamics of chloride in HF pathophysiology. 
FIGURE 3
Scatterplot of individual serum sodium and chloride concentrations at A, worsening of heart failure and B, its recovery after conventional diuretic therapy. A symbol is used when two or three data points overlap. All data points are shown in the range plotted
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